Cholera Vaccines Market to Reach USD 167.3 Million by 2030, Fueled by a CAGR of 9.0% from 2030 | MarketDigits [Yahoo! Finance]
Emergent Biosolutions, Inc. (EBS)
Last emergent biosolutions, inc. earnings: 4/30 04:08 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.emergentbiosolutions.com
Company Research
Source: Yahoo! Finance
forecast period owing to the presence of advanced research and the major players that is leading to the development of a novel cholera vaccine, a high number of cholera cases recorded globally, and rising government initiatives. Richmond, Feb. 27, 2024 (GLOBE NEWSWIRE) -- According to MarketDigits, the Cholera Vaccines Market was valued USD 91.50 Million in 2023 and projected to reach USD 167.3 Million by 2030, growing at a CAGR of 9.0% during the forecast period of 2023-2030. Major vendors in the global Cholera Vaccines Market: Astellas Pharma Inc., Emergent BioSolutions Inc., GlaxoSmithKline plc (GSK), Merck & Co. Inc., and Mitsubishi Tanabe Pharma Corporation, Sanofi, Takeda Pharmaceutical Co. Ltd, Valneva SE, PaxVax Inc., Pfizer Inc. and Others. The Cholera Vaccines Market is a dynamic sector within the global pharmaceutical industry focused on the development, production, and distribution of vaccines aimed at preventing cholera infections. Cholera, a severe diarrheal diseas
Show less
Read more
Impact Snapshot
Event Time:
EBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EBS alerts
High impacting Emergent Biosolutions, Inc. news events
Weekly update
A roundup of the hottest topics
EBS
News
- Emergent Biosolutions lays off 300 people [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Reports First Quarter 2024 Financial ResultsGlobeNewswire
EBS
Earnings
- 3/6/24 - Miss
EBS
Sec Filings
- 5/2/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 5/1/24 - Form 8-K
- EBS's page on the SEC website